Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2019 second-quarter earnings
FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 Second-Quarter Earnings-Q2 2019 earnings

What you need to know about Johnson & Johnson’s 2019 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Our solid second-quarter results can be attributed to the dedication and hard work of our Johnson & Johnson colleagues around the world, who perpetually strive to bring differentiated healthcare solutions to the most pressing unmet medical needs,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we remain focused on delivering value to all of our stakeholders, we will continue to optimize our portfolio to ensure we make progress against our long-term strategies. Our results during the first half of this year reaffirm our confidence in our 2019 outlook, and position us well to invest for continued success in the future.”

For more details about the company’s second-quarter 2019 results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


2019 Q2 Earnings infographic

Johnson & Johnson’s 2019 2nd-Quarter Earnings

Read the earnings press release, which includes full financial details for the second quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

More from Johnson & Johnson

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.